What stage does Crescent Capital Partners invest at?

Crescent Capital Partners invests at the Growth, Late Stage stages.

What is Crescent Capital Partners's typical check size?

Crescent Capital Partners typically writes checks of $13.2M – $52.8M.

Where is Crescent Capital Partners located?

Crescent Capital Partners is headquartered in Sydney, AU.

Does Crescent Capital Partners lead rounds?

Yes, Crescent Capital Partners leads investment rounds.

Crescent Capital Partners

Private equity

Sydney · Growth–Late Stage · 24 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Crescent Capital Partners

Paths you didn't know you had: your email and LinkedIn already hold routes to the Crescent Capital Partners team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

Crescent Capital Partners focuses on mid-market and lower mid-market private equity in Australia and New Zealand, using a high-engagement, active investment model to support portfolio businesses with growth and strategic initiatives. Roughly half its investments are in the Australian healthcare sector. Beyond buyouts, the firm has expanded into alternative strategies including an open-ended evergreen private equity fund, diversified Australian corporate loan private credit funds, and a listed equities practice built on fundamental research and active engagement. ESG considerations are embedded across the investment lifecycle to support business resilience and long-term value creation.

Invests inAdvanced Manufacturing Biotech Construction Tech Consumer EdTech Enterprise Software Fintech FoodTech Hardware Healthtech Medical Devices Mobility & Transportation Retail TechSector AgnosticAsia-Pacific Australia Brazil New Zealand Sydney

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Growth–Late Stage

Check

$13.2M – $52.8M

Sydney, New South Wales, AU

Leads rounds

Leads

Instruments

Equity · Debt

Founded

2000

AUM

$2B

Team · 24 people

from the firm's website & curated & public directories

Michael Alscher· Founder and Managing Partner· Greater Sydney Areain

Founder and Managing Partner with over 35 years in strategy consulting, investment, business management and public company boards. Previously worked at Bain & Company, LEK Partnership and Chase Manhattan Bank; chairs several portfolio companies.

alscher@crescentcap.com.au

Todd Hixon· Founder and Managing Partnerin 𝕏

Todd Hixon invests broadly in information technology businesses, focusing on companies using deep technology to create commercial value. He co-founded New Atlantic Ventures in 2006, previously served as managing partner of the DFJ New England Fund and as a Senior Vice President at The Boston Consulting Group, and holds a BA in Physics from Princeton and an MBA from Harvard Business School.

todd@nav.vc

Ondrej Ruzicka· Managing Partner Crescent Growth· Greater Sydney Areain

Managing Partner of Crescent Growth with 16+ years in private equity and investment banking focused on consumer and healthcare across ANZ, Europe and Asia. Formerly Managing Director and Head of ANZ at L Catterton and roles at Goldman Sachs, Nomura and UBS.

Russell Sinclair· Managing Partner Private Credit· Greater Sydney Areain

Managing Partner for Private Credit with 30+ years in banking and finance. Former PwC Partner and senior debt and structured finance leader at Westpac.

Simon Birrell· Managing Partner Listed Equities· London Area, United Kingdomin

Managing Partner for Listed Equities with 20+ years in listed equities, private equity and strategy consulting across the US, Europe and Australia. Former portfolio manager at VGI Partners, Antipodes Partners and Manikay Partners.

Daren McKennay· Partner· Greater Sydney Areain

Partner with 35+ years in the healthcare sector as a CEO and in private equity. Previously co-founder and CEO of Life Healthcare Group, COO of MIA Group and CEO of Healthcare of Australia.

mckennay@crescentcap.com.au

Nathanial Thomson· Partner

Partner with 25 years of experience across strategy consulting, private equity and banking. Formerly at McKinsey & Company; chairs several portfolio companies.

thomson@crescentcap.com.au

Neville Buch· Partner

Partner with 40+ years of experience in operating roles and M&A. Former Global Deputy Chairman of Tyco Fire & Security and CEO of Tyco Fire and Security Asia Pacific.

buch@crescentcap.com.au

Peter Lyon-Mercado· Partner· Greater Boston

Partner with 35+ years of experience in financial management and accounting. Previously worked at Saffery in London.

lyon-mercado@crescentcap.com.au

Stuart Butterworth· Partner

Partner with 15+ years in strategy consulting and private equity. Previously at A.T. Kearney; chairs EMAPTA and Walski.

butterworth@crescentcap.com.au

Elizabeth Burgess· Managing Partner | Crescent Growth· United Statesin

Katie Hastings· Managing Partner - Private Credit· United Kingdomin

Giuseppe Valletta· Investment Director· Hong Kong SARin

Investment Director with extensive private equity and investment banking experience focused on consumer and healthcare. Previously a Principal at L Catterton and roles at Goldman Sachs, Pacific Capital and Citi.

Patrick Schmidt· Investment Director

Investment Director with 10+ years across private equity, strategy consulting and M&A. Formerly at McKinsey & Company and King & Wood Mallesons; director of Pinnacle Rehab.

Emily Yang· ESG Director· Xuhui District, Shanghai, Chinain

Managing Director at Cenova Capital who was previously a VP at Duff & Phelps and worked at a risk consulting firm and PwC. Holds degrees from Shanghai University of Finance and Economics and Cass Business School; CFA charterholder with ACCA qualification.

Caitlin Spitzke· CFO/COO Private Credit

CFO/COO of Private Credit with 12+ years in financial management, accounting and operations. Previously at MA Financial Group, Dexus and PwC.

Cressida Mort· Director Investor Relations

Director of Investor Relations with broad experience in relationship management, fundraising and marketing. Previously worked at NAB, ASX and The Armidale School.

Dan Waine· Director New Investments· Greater Sydney Areain

Director of New Investments with 25 years across professional services, banking and private equity. A Chartered Accountant formerly at Ernst & Young.

Eugen Lamotte· CFO Private Equity Funds

CFO of the Private Equity Funds with 12+ years in private equity. Previously worked at Ernst and Young.

Lucy Cooper· Director ESG· Sydney, New South Wales, Australiain

Director of ESG with 10+ years of experience in ESG, sustainable finance and consulting across public and private sectors. Formerly at Bain & Company and the Australian Renewable Energy Agency (ARENA).

Matthew Thomson· Assistant Portfolio Manager· Sydney, New South Wales, Australiain

Assistant Portfolio Manager with 10+ years in listed equities and investment banking. Former portfolio manager at Peregrine Capital in South Africa and Firetrail Investments in Australia.

Peter Scrine· Director Business Development

Director of Business Development with a track record originating investment opportunities and supporting acquisition strategies. Formerly General Manager at WIN Radio and National Partnership Director at Austereo.

David A. Mortimer· Director· Greater Sydney Areain

Timothy D. Martin· Director

Frequently asked questions

What stage does Crescent Capital Partners invest at?: Crescent Capital Partners invests at the Growth, Late Stage stages.
What is Crescent Capital Partners's typical check size?: Crescent Capital Partners typically writes checks of $13.2M – $52.8M.
What sectors does Crescent Capital Partners focus on?: Crescent Capital Partners focuses on Advanced Manufacturing, Biotech, Construction Tech, Consumer, EdTech, Enterprise Software, Fintech, FoodTech, Hardware, Healthtech, Medical Devices, Mobility & Transportation, Retail Tech, Sector Agnostic.
Where is Crescent Capital Partners located?: Crescent Capital Partners is headquartered in Sydney, AU.
Does Crescent Capital Partners lead rounds?: Yes, Crescent Capital Partners leads investment rounds.

Images

Similar investors

Advent International

Advent International is a global private equity firm that partners with management teams to build market leaders through buyouts, corporate carve-outs, and value creation across selected sectors.

$1.1B

Business Growth Fund

BGF is a UK and Ireland investor providing minority, patient growth capital and support to entrepreneurial small and medium-sized businesses, from early-stage deep tech and life sciences startups to established scaling companies.

$3.8M – $38M

MPG Fund

MPG Fund is an early-stage venture investor backing technology startups.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.

$250K

Norwest Venture Partners

Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.

$10M – $30M